We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTN icon
2301
Marten Transport
MRTN
$1.22B
$16K ﹤0.01%
+1,281
New +$16K
PJT icon
2302
PJT Partners
PJT
$4.38B
$16K ﹤0.01%
401
+145
+57% +$5.91K
PRTH icon
2303
Priority Technology Holdings
PRTH
$444M
$16K ﹤0.01%
1,998
+1,958
+4,895% +$12.5K
QNCX icon
2304
Quince Therapeutics
QNCX
$29.5M
$16K ﹤0.01%
+2
New +$11.9K
RDI icon
2305
Reading International Class A
RDI
$34.3M
$16K ﹤0.01%
1,211
+127
+12% +$1.83K
SANW
2306
DELISTED
S&W Seed Co
SANW
$16K ﹤0.01%
317
-58
-15% -$3K
VICR icon
2307
Vicor
VICR
$10.2B
$16K ﹤0.01%
504
+201
+66% +$6.46K
WDAY icon
2308
Workday
WDAY
$44.4B
$16K ﹤0.01%
+78
New +$15.8K
WPRT
2309
Westport Fuel Systems
WPRT
$35.7M
$16K ﹤0.01%
564
-383
-40% -$8.51K
PMD
2310
DELISTED
Psychemedics Corporation
PMD
$16K ﹤0.01%
1,543
+1,298
+530% +$14.7K
NGM
2311
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$16K ﹤0.01%
+1,072
New +$15.7K
BKCC
2312
DELISTED
BlackRock Capital Investment Corporation
BKCC
$16K ﹤0.01%
2,600
-4,400
-63% -$27K
APTX
2313
DELISTED
Aptinyx Inc. Common Stock
APTX
$16K ﹤0.01%
4,659
-1,974
-30% -$7.02K
FNHC
2314
DELISTED
FedNat Holding Company Common Stock
FNHC
$16K ﹤0.01%
1,089
-4,415
-80% -$67.3K
NTUS
2315
DELISTED
Natus Medical Inc
NTUS
$16K ﹤0.01%
638
+229
+56% +$5.83K
SBBP
2316
DELISTED
Strongbridge Biopharma plc.
SBBP
$16K ﹤0.01%
5,123
+848
+20% +$3.11K
MYOK
2317
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$16K ﹤0.01%
+314
New +$15.3K
CLUB
2318
DELISTED
Town Sports International Holdings, Inc.
CLUB
$16K ﹤0.01%
7,449
+5,250
+239% +$17.6K
DNR
2319
DELISTED
Denbury Resources, Inc.
DNR
$16K ﹤0.01%
12,634
+12,032
+1,999% +$21.9K
NRCG
2320
DELISTED
NRC Group Holdings Corp.
NRCG
$16K ﹤0.01%
+1,418
New +$12.6K
TYPE
2321
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$16K ﹤0.01%
955
+507
+113% +$9.03K
HTZ.RT
2322
DELISTED
Hertz Global Holdings
HTZ.RT
$16K ﹤0.01%
+7,238
New +$16K
EE
2323
DELISTED
El Paso Electric Company
EE
$16K ﹤0.01%
+241
New +$14.8K
AAOI icon
2324
Applied Optoelectronics
AAOI
$11.5B
$15K ﹤0.01%
1,496
-5,574
-79% -$59.6K
AMBA icon
2325
Ambarella
AMBA
$3.81B
$15K ﹤0.01%
348
-278
-44% -$12.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.